COMMUNIQUÉS West-GlobeNewswire

Adamas Announces New Employment Inducement Grant
08/12/2017
EMERYVILLE, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that the compensation committee of the company’s board of directors granted 64 new employees the option [...]
New Sensory Friendly Reading with Dogs Library Event - 12/13/17
08/12/2017
FULLERTON, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Fullerton Cares Autism Foundation is teaming up with the Fullerton Public Library to provide a sensory friendly reading time where children of all needs can meet, [...]
Galena Biopharma Reminds Shareholders to Vote Ahead of Special Meeting on December 15, 2017
08/12/2017
SAN RAMON, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE) would like to remind stockholders to vote their respective shares and support the business combination transaction with SELLAS [...]
Burcon Announces Board Change and Confirms No Material Undisclosed Information
08/12/2017
VANCOUVER, British Columbia, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Corporation”), announced that effective today, Mr. Matthew Hall has resigned as [...]
GENFIT: ADDITIONAL RESOURCES ALLOCATED TO THE LIQUIDITY AGREEMENT
08/12/2017
GENFIT: ADDITIONAL RESOURCES ALLOCATED TO THE LIQUIDITY AGREEMENT Lille (France), Cambridge (Massachusetts, United States), December 8, 2017 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a biopharmaceutical company at [...]
GENFIT : APPORT COMPLEMENTAIRE AU CONTRAT DE LIQUIDITE
08/12/2017
GENFIT : APPORT COMPLEMENTAIRE AU CONTRAT DE LIQUIDITE Lille (France), Cambridge (Massachusetts, Etats-Unis), le 8 décembre 2017 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), société biopharmaceutique engagée dans [...]
Micron Solutions, Inc. Designates Mr. E. P. Marinos as a Director Emeritus and Appoints Mr. Andrei Soran to its Board of Directors
08/12/2017
FITCHBURG, Mass., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American:MICR) (“Micron” or the “Company”), announced the retirement of Mr. E. P. (“Lou”) Marinos from the Company’s Board of Directors [...]
Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants
08/12/2017
OTTAWA, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that support and optimize [...]
American Health Council Honors Julio C. Soto, MD as “Best in Medicine”
08/12/2017
NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) -- The American Health Council honors Julio C. Soto, MD as “Best in Medicine” for his wealth of medical expertise and commitment to increased patient autonomy over their medical [...]
Akers Biosciences Secures Further Intellectual Property Protection for Akers Wellness Line
08/12/2017
THOROFARE, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that its Health and [...]
Medifirst Solutions Announces Shareholder Update
08/12/2017
Freehold, NJ , Dec. 08, 2017 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML- [...]
Oxford Performance Materials Sells Aerospace & Defense Business to Strategic Investor Hexcel Corporation
08/12/2017
SOUTH WINDSOR, Conn., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM™), today announced that it has [...]
Biohit Oyj’s Financial Reporting and Annual General Meeting in 2018
08/12/2017
Biohit Oyj Financial calendar, December 8, 2017 at 4:00 pm local time (EET) Biohit Oyj will release its financial statements for 2017 on Wednesday 28 th of February 2018 at 9:30 am. The Annual Report, which contains the [...]
Asklepion Pharmaceuticals Presents Phase 1b/2a Clinical Trial Data for IV-Citrulline at the Pediatric Cardiac Intensive Care Society 13th Annual International Meeting
08/12/2017
BALTIMORE, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Asklepion Pharmaceuticals, LLC (“Asklepion” or “the Company”), a biotechnology company focused on the development of IV-citrulline for rare pediatric diseases, announced [...]
Cancer Genetics Prices $7 Million Registered Direct Offering
08/12/2017
RUTHERFORD, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced the pricing of a [...]
Fennec Announces Pricing of Public Offering
08/12/2017
RESEARCH TRIANGLE PARK, N.C., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC ) (TSX: FRX ), a biotechnology company focused on the development of PEDMARK TM (a unique formulation of sodium [...]
Marrone Bio Innovations Announces the Availability of Amplitude™ Biofungicide for White Mold Control in the 2018 Growing Season
08/12/2017
DAVIS, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]
TG Therapeutics, Inc. Recaps Data Presentations at the Upcoming 59th American Society of Hematology Annual Meeting
08/12/2017
NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ), today recapped the schedule of data presentations for the Company’s lead compounds, TGR-1202, (umbralisib), the Company's once-daily [...]
Allscripts hits record-breaking 1 billion API data shares in a single year
08/12/2017
CHICAGO, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) continues to lead the industry in innovation, interoperability, data sharing, and connectivity as it hits an industry leading milestone of one [...]

Pages